Locus BiosciencesMorrisville, North Carolina, United States
Disclosure(s): No financial relationships to disclose
509 - Pseudomonas aeruginosa-specific CRISPR-Cas3 bacteriophage cocktail developed to treat respiratory and bloodstream infections
Saturday, October 19, 202410:30 AM – 10:42 AM US PT